Try it
Pharmacology · Pharmacogenetics: prodrug and enzyme inhibition
Sample itemA 45-year-old woman on paroxetine for depression is prescribed codeine for post-operative pain and reports almost no analgesia, though she takes it as directed. What explains this?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Paroxetine inhibits CYP2D6, so codeine is not converted to morphine
Codeine is a prodrug whose analgesia depends largely on O-demethylation to morphine by CYP2D6. Strong CYP2D6 inhibitors such as paroxetine and fluoxetine, or genetic poor metabolism, give little analgesia. The opposite occurs in ultra-rapid metabolisers, who can develop morphine toxicity.
Option by option
A. Urinary acidification by paroxetine accelerates codeine excretion
Paroxetine does not acidify urine and codeine elimination is not pH dependent in this way.
B. Paroxetine competes with codeine at mu receptors
Paroxetine has no appreciable mu receptor affinity.
C. Paroxetine inhibits CYP2D6, so codeine is not converted to morphine (correct)
Correct. Without CYP2D6 activity the active metabolite is formed in only small amounts.
D. Paroxetine induces CYP3A4, so codeine is cleared before it acts
Paroxetine is an inhibitor rather than an inducer, and CYP3A4 yields inactive norcodeine.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?